Gilead files remdesivir for EU approval, with a verdict poss...

The EMA has said it will fast-track the review of Gilead Sciences’ remdesivir as a treatment for COVID-19, after the US biopharma submitted its marketing application for the dr

hVIVO offers coronavirus antibody testing to UK employers

UK firm hVIVO has launched a coronavirus antibody testing service for big businesses that it says could help get employees back to work as lockdown eases.

Hot shots named in Trump’s Warp Speed drive for coronavirus ...

President Donald Trump’s Operation Warp Speed, which aims to make a coronavirus vaccine widely available by year-end, has come up with a shortlist of candidates, with some nota

PureTech unit Follica cues up phase 3 programme for male hai...

PureTech has said one of the companies it has founded – Follica – is preparing to start registration trials for its drug-device therapy for treating male pattern baldness in th

Gilead's remdesivir could be $7.7bn blockbuster - analyst

An influential analyst has upped his previously cautious assessment of the sales potential of Gilead’s COVID-19 drug remdesivir, saying sales could reach $7.7 billion in 2022. 

FDA clears emergency use of Roche test for COVID-19 'cytokin...